research use only
Z-IETD-FMK (Caspase-8 Inhibitor, Z-IE(OMe)TD(OMe)-FMK) is a specific Caspase-8 inhibitor. This compound is also an inhibitor of granzyme B.
| Related Targets | Caspase-1 Caspase-3 Caspase-8 Caspase-9 Caspase-4 Capase-7 Caspase-2 Caspase-5 Caspase-6 Caspase-10 Caspase-7 | Click to Expand |
|---|---|---|
| Related Products | Z-VAD-FMK Belnacasan (VX-765) Z-DEVD-FMK Q-VD-Oph Emricasan (IDN-6556) Ac-DEVD-CHO Z-LEHD-FMK TFA Z-VAD(OH)-FMK (Caspase Inhibitor VI) PAC-1 Z-YVAD-FMK Apoptosis Activator 2 Tasisulam Phenoxodiol (Haginin E) | Click to Expand |
| Related Compound Libraries | Autophagy Compound Library Apoptosis Compound Library Ferroptosis Compound Library Pyroptosis Compound Library Mitochondria-Targeted Compound Library | Click to Expand |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| HepG2 | Function assay | Z-IETD-FMK accelerates the PPI-induced cell death of HepG2 cells. | 30671458 | |||
| HL-60 | Function assay | 50 μM | 1 h | completely blocks the 23-HUA-induced DNA fragmentation | 30551620 | |
| MG63 | Cytotoxicity assay | 10 μM | partially reversed MSP-4-induced MG63 cell cytotoxicity | 29301308 | ||
| HXO-RB44 cells | Apoptosis assay | decreases the apoptotic rates induced by bufalin | 27904697 | |||
| Jurkat cells | Function assay | 50 μM | 1 h | abolishes the cleavage of tBid | 25632401 | |
| DU 145 | Function assay | 20 μM | 24 h | interrupted the cleavage of PARP induced by ergosterol peroxide | 25506265 | |
| Click to View More Cell Line Experimental Data | ||||||
| Targets |
|
|---|
In vitro |
||||
| In vitro | Z-IETD-FMK, which inhibits the cleavage of caspase-8 and partially inhibits the cleavage of caspase-3 and PARP, prevents the execution of apoptosis in retinal cells exposed to different apoptotic stimuli. [1] This compound (50 μM) reduces ceramide-induced cardiomyocyte death and significantly inhibits the activation of caspase 3. [2] Inhibition of caspase-8 by this chemical affects the generation of activated/memory T cells and T cell cytokine production, and decreases NF-kappaB responses to TCR:CD3 engagement in T cell cultures. [3] |
|||
|---|---|---|---|---|
| Cell Research | Cell lines | Rat neonatal cardiomyocytes | ||
| Concentrations | 50 µM | |||
| Incubation Time | 24 h | |||
| Method | Drugs were added to the cell culture medium simultaneously with ceramide, and surviving cells were counted 24 hours later. |
|||
In Vivo |
||
| In vivo | In vivo, inhibition of caspase-8 by Z-IETD-FMK reduces memory/activated CD4 and CD8 T cells, and increases susceptibility to T. cruzi infection. [3] This compound promotes neuronal survival and regeneration of injured retinal ganglion cells after CNS injuries. [4] |
|
|---|---|---|
| Animal Research | Animal Models | T. cruzi-infected mice |
| Dosages | 0.4 mg/3 days | |
| Administration | -- | |
References |
|
| Molecular Weight | 654.68 | Formula | C30H43FN4O11 |
| CAS No. | 210344-98-2 | SDF | Download SDF |
| Synonyms | Caspase-8 Inhibitor, Z-IE(OMe)TD(OMe)-FMK | ||
| Smiles | CCC(C)C(C(=O)NC(CCC(=O)OC)C(=O)NC(C(C)O)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)OCC1=CC=CC=C1 | ||
| Storage (From the date of receipt) | |||
|
In vitro |
DMSO : 100 mg/mL ( (152.74 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.) Water : Insoluble Ethanol : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
|||||
Molarity Calculator
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
* Indicates a Required Field